Clinical Trials Logo
  1. Home
  2. Invasive Pneumococcal Disease
  3. NCT00227188
  4. Details
NCT00227188 Clinical Trial

Study Evaluating Prevenar in the Prevention of Invasive Pneumococcal Disease (IPD) in the Paediatric Population in Spain.

Invasive Pneumococcal Disease Clinical Trial

Official title:
Effectiveness of Prevnar in the Prevention on IPD in the Paediatric Population in Spain

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT00227188
Other study ID # 0887-101317
Secondary ID
Status Completed
Phase N/A
First received September 13, 2005
Last updated November 28, 2012
Start date May 2003
Est. completion date December 2005

Study information
Verified date November 2012
Source Pfizer
Contact n/a
Is FDA regulated No
Health authority Spain: Comité Ético de Investigación Clínica
Study type Observational

Clinical Trial Summary

The aim of this study is to evaluate the postlicensure effectiveness of Prevnar in the prevention of IPD in the Spanish paediatric population (children younger than 5 years)

Recruitment information / eligibility
Status Completed
Enrollment 408
Est. completion date December 2005
Est. primary completion date December 2005
Accepts healthy volunteers No
Gender Both
Age group N/A to 5 Years
Eligibility Inclusion Criteria:

- All children from 0 up to 5 years attending to the hospital's emergency department will be evaluated for IPD.

- Diagnosis of IPD will be based on positive pneumococcal isolation in any sterile location, such us blood or spinal fluid.

Study Design

Time Perspective: Prospective

Related Conditions & MeSH terms

Intervention

Drug:
• Pneumococcal 7-valent conjugate vaccine Prevnar

Locations
Country Name City State
Spain Pfizer Investigational Site Bilbao

Sponsors (1)
Lead Sponsor Collaborator
Pfizer

Country where clinical trial is conducted

Spain, 

See also
  Status Clinical Trial Phase
Completed NCT00853749 - Immune Response In Children Revaccinated With Pneumococcal Conjugate Vaccine Phase 3
Recruiting NCT00885625 - 7-valent Pneumococcal Conjugated Vaccination Phase 4
Completed NCT04464291 - An Epidemiological Survey to Establish the Spectrum of Circulating Serotypes of S. Pneumoniae, in Patients Older 18 Years N/A
Completed NCT01128439 - Study Estimating the Impact of Prevnar 13™ (13vPnC) on Invasive Pneumococcal Disease
Completed NCT01083459 - Impact of PCV on Disease and Colonization Among Native American Communities N/A
Completed NCT00371878 - Immunogenicity of 7-Valent Pneumococcal Conjugate Vaccine in Lung Fluid of Adults With and Without HIV Infection Phase 4

External Links